Genicular artery embolization for knee osteoarthritis

Research into genicular artery embolization (GAE) as a treatment for knee osteoarthritis has highlighted both its potential benefits and the need for more rigorous scientific validation.

A meta-analysis published in ‘Skeletal Radiology’ indicated that GAE may alleviate pain and improve function for up to twelve months. However, the German Society for Endoprosthetics (AE) has urged caution, noting that many reviewed studies were uncontrolled. Experts, such as Professor Georgi Wassilew, emphasized the difficulty in proving that improvements are directly caused by the procedure rather than other factors, calling for further research involving sham treatments.

Subsequent reports from researchers at the University of Colorado describe GAE as a minimally invasive alternative to knee replacement surgery. The procedure involves using a catheter to block abnormal blood vessels associated with inflammation to reduce swelling and chronic pain. While it does not repair cartilage, clinical studies, including a randomized controlled trial in ‘European Radiology’, have shown reductions in pain and improved mobility over 12 months. The treatment is considered most promising for patients with mild to moderate osteoarthritis who have not responded to conservative therapies.